Oncology

Evaluation of Confocal Laser Endomicroscopy for Detection of Occult Gastric Carcinoma in CDH1 Variant Carriers
Samuel A Schueler, Lauren Gamble, Bryan Curtin, Samantha Ruff, Maureen Connolly, Cathleen Hannah, Martha Quezado, Markku Miettinen, Maureen George, Andrew Blakely, Jonathan Hernandez, Theo Heller, Christopher Koh, Jeremy L Davis

medRxiv 2020.06.01.20118471; doi: https://doi.org/10.1101/2020.06.01.20118471
Clinical identification of malignant pleural effusions in the emergency department
GEORGIOS T. STATHOPOULOS

medRxiv 2020.05.31.20118307; doi: https://doi.org/10.1101/2020.05.31.20118307
Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype
Scott G Williams, Franco Caramia, Han Xian Aw Yeang, Catherine Mitchell, David J Byrne, Stephen B Fox, Paul J Neeson, Sue Haupt, Ygal Haupt, Simon P Keam

medRxiv 2020.06.01.20115345; doi: https://doi.org/10.1101/2020.06.01.20115345
Toll-like Receptor 9 in breast carcinoma is a good prognostic marker in patients treated with neoadjuvant chemotherapy
ARADHANA SINGH, ARGHYA BANDYOPADHYAY, NARENDRANATH MUKHERJEE, ANUPAM BASU

medRxiv 2020.05.28.20114850; doi: https://doi.org/10.1101/2020.05.28.20114850
Human papillomavirus (HPV) prevalence in relation with cervical cytology in Bengali population of India
Puja Banerjee, Arghya Bondhopadhyay, Bibek Mohan Rakshit, Amitava Pal, ANUPAM BASU

medRxiv 2020.06.01.20119628; doi: https://doi.org/10.1101/2020.06.01.20119628
Plasma ceramides as a sexually dimorphic biomarker of pancreatic cancer-induced cachexia.
Jeffery M. Chakedis, Mary E. Dillhoff, Carl R. Schmidt, Priyani V. Rajasekera, David C. Evans, Terence M. Williams, Denis C. Guttridge, Erin E Talbert

medRxiv 2020.06.01.20111492; doi: https://doi.org/10.1101/2020.06.01.20111492
Evaluation of COVID 19 infection in 279 cancer patients treated during a 90-day period in 2020 pandemic
Mozaffar Aznab

medRxiv 2020.05.26.20102889; doi: https://doi.org/10.1101/2020.05.26.20102889
Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency
Alvina G Lai, Laura Pasea, Amitava Banerjee, Spiros Denaxas, Michail Katsoulis, Wai Hoong Chang, Bryan Williams, Deenan Pillay, Mahdad Noursadeghi, David Linch, Derralynn Hughes, Martin D Forster, Clare Turnbull, Natalie K Fitzpatrick, Kathryn Boyd, Graham R Foster, Matt Cooper, Monica Jones, Kathy Pritchard-Jones, Richard Sullivan, Geoff Hall, Charlie Davie, Mark Lawler, Harry Hemingway

medRxiv 2020.05.27.20083287; doi: https://doi.org/10.1101/2020.05.27.20083287
Association of extended dosing intervals or delays in pembrolizumab-based regimens with survival outcomes in advanced non-small cell lung cancer
Kartik Sehgal, Anushi Bulumulle, Heather Brody, Ritu Gill, Shravanti Macherla, Aleksandra Qilleri, Danielle C McDonald, Cynthia R Cherry, Meghan Shea, Mark S Huberman, Paul A VanderLaan, Glen J Weiss, Paul R Walker, Daniel B Costa, Deepa Rangachari

medRxiv 2020.03.31.20048637; doi: https://doi.org/10.1101/2020.03.31.20048637
Comparison of Population Characteristics in Real-World Clinical Oncology Databases in the US: Flatiron Health, SEER, and NPCR
Xinran Ma, Lura Long, Sharon Moon, Blythe J.S. Adamson, Shrujal S. Baxi

medRxiv 2020.03.16.20037143; doi: https://doi.org/10.1101/2020.03.16.20037143

Oncology

Pages